Skip to content

A program of International Vaccine Access Center by Johns Hopkins Bloomberg School of Public Health

Value of Immunization Compendium of Evidence

Home
Evidence Briefs
Knowledge Hub
Advocacy
Vaccine Resources
About VoICE

Impact of national ten-valent pneumococcal conjugate vaccine program on reducing antimicrobial use and tympanostomy tube placements in Finland

Post navigation

← Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya

Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

© 2024 The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved

Translation Disclaimer